从癌前生物学到精确拦截:通过精心策划的一系列受邀文章连接点
Karen Colbert Maresso1, Anirban Maitra2,3, Ernest T Hawk1,4
1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer prevention research (Philadelphia, Pa.)
|July 5, 2023
概括
了解癌前进化是预防癌症的关键. 人类瘤图谱网络 (HTAN) 正在利用新技术推进癌前疾病的研究,开发早期检测和拦截策略.
科学领域:
- 在瘤学瘤学.
- 系统生物学 系统生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 前癌症是几乎所有癌症的可识别的前体,为拦截提供了一个关键的窗口.
- 对癌前进化和微环境影响的有限知识阻碍了有效的拦截策略.
- 最近的技术进步使得高分辨率的癌前研究成为可能.
研究的目的:
- 审查人类瘤图谱网络 (HTAN) 在研究癌前病症方面取得的进展.
- 概述HTAN和癌前生物学领域的未来方向.
- 确定开发早期检测,风险预测和拦截代理的经验教训.
主要方法:
- 人类瘤图谱网 (HTAN) 于2018年推出,作为博·拜登国家癌症月球计划的一部分.
- 五个HTAN小组专注于分析乳腺,结肠,皮肤和肺部的癌前状况.
- 一个特别的专家邀请的评论集综合了当前的知识和未来的前景.
主要成果:
- 通过高分辨率分析,HTAN在了解癌前生物学方面取得了重大进展.
- 在描述各种癌前瘤的进化和微观环境方面取得了进展.
- 该倡议激发了开发新型拦截策略的努力.
结论:
- 持续的研究和HTAN内部的合作对于加速癌症预防至关重要.
- 从HTAN中吸取的教训可以指导改进早期检测和风险预测生物标志物的开发.
- 跨学科的方法对于将癌前研究转化为临床应用至关重要.
相关概念视频
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


